Literature DB >> 3409220

Isolation and characterization of a complementary DNA clone for a Mr 32,000 protein which is induced with tumor promoters in BALB/c 3T3 cells.

H Kageyama1, T Hiwasa, K Tokunaga, S Sakiyama.   

Abstract

The synthesis of a protein of Mr 32,000 (p32) is enhanced by various tumor promoters, chemical carcinogens, metal salts, and heat shock in BALB/c 3T3 cells. We have isolated a complementary DNA (cDNA) clone for p32 from a lambda gt10 library of BALB/c 3T3 cells. The library was constructed from mRNA extracted from the cells treated with sodium arsenite, which stimulates the p32 expression most effectively among various agents so far tested. Having screened this library differentially with probes which represent induced and uninduced mRNA populations for p32, we first obtained a partial p32 cDNA clone and have subsequently succeeded in the isolation of a cDNA clone containing the entire coding sequence. RNA blot analysis has shown that p32 mRNA is induced as early as 0.5 h after the addition of 12-O-tetradecanoyl-phorbol-13-acetate or sodium arsenite. Computer-assisted comparison with GenBank data has revealed a striking similarity in the nucleotide sequences between cDNAs of p32 and rat heme oxygenase. These results strongly suggest that p32 is a mouse homolog of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409220

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Ncb5or deficiency increases fatty acid catabolism and oxidative stress.

Authors:  Ming Xu; WenFang Wang; Jennifer R Frontera; Melanie C Neely; Jianghua Lu; Daniel Aires; Fong-Fu Hsu; John Turk; Russell H Swerdlow; Susan E Carlson; Hao Zhu
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

2.  Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.

Authors:  P Salonpää; K Krause; O Pelkonen; H Raunio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

Review 3.  Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

4.  Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.

Authors:  F Liao; A Andalibi; J H Qiao; H Allayee; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

5.  Identification of a cis-regulatory element and putative trans-acting factors responsible for 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated induction of heme oxygenase expression in myelomonocytic cell lines.

Authors:  Y Muraosa; S Shibahara
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Authors:  F Liao; A Andalibi; F C deBeer; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids.

Authors:  L Cantoni; C Rossi; M Rizzardini; M Gadina; P Ghezzi
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

8.  Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite.

Authors:  S M Keyse; R M Tyrrell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 9.  Carbon monoxide: present and future indications for a medical gas.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

10.  Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.

Authors:  Y Yan; K Higashi; K Yamamura; Y Fukamachi; T Abe; S Gotoh; T Sugiura; T Hirano; T Higashi; M Ichiba
Journal:  Jpn J Cancer Res       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.